Journal Report

CANCER

Download PDF
Journal Information
Journal Title
CANCER
Publisher
WILEY
ISSN
0008-543X
E-ISSN
1097-0142
Database
Clarivate
Domain
Health Sciences, Life Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
CAR T‐cell data indicate durable disease control, potential cure
Leah Lawrence
2026-11-1 Vol. 132 Issue 21
DOI: 10.1002/cncr.70618
Decision regret following rapid genetic testing at the time of breast cancer diagnosis
Ling‐Fang Hsu, Andrea Eisen, Aletta Poll et al.
2026-11-1 Vol. 132 Issue 21
DOI: 10.1002/cncr.70663
Telehealth tobacco cessation doubles quit rates in patients with cancer
Leah Lawrence
2026-11-1 Vol. 132 Issue 21
DOI: 10.1002/cncr.70617
Liposomal irinotecan and capecitabine plus bevacizumab as second‐line therapy in metastatic colorectal cancer: A multicenter, single‐arm study
Dan Su, Changzheng Li, Tongsen Zheng et al.
2026-11-1 Vol. 132 Issue 21
DOI: 10.1002/cncr.70671
Eltrombopag during induction chemotherapy in older patients with newly diagnosed acute myeloid leukemia is safe and reduces platelet transfusion requirements: The EPAG‐2015 French Innovative Leukemia Organization phase 2 randomized trial
Arnaud Pigneux, Pierre‐Yves Dumas, Marc Bernard et al.
2026-10-30 Vol. 132 Issue 21
DOI: 10.1002/cncr.70669
A multicenter, prospective, phase 2 trial on proton re‐irradiation for patients with previously treated head and neck cancer
Edward Christopher Dee, Christopher A. Barker, Noah S. Kalman et al.
2026-10-30 Vol. 132 Issue 21
DOI: 10.1002/cncr.70643
The evolving role of perioperative systemic therapy in bladder cancer
Saad O. Atiq, Jonathan F. Anker, Eric J. Miller et al.
2026-10-30 Vol. 132 Issue 21
DOI: 10.1002/cncr.70629
Structured rehabilitation for terminal cancer: Aligning the evidence with the setting that funds it
Makoto Kodaira
2026-10-27 Vol. 132 Issue 21
DOI: 10.1002/cncr.70658
Maintenance therapy with low dose cyclophosphamide does not increase the risk of second malignancies: The European Pediatric Soft Tissue Sarcoma Study Group RMS2005 study experience
Gianni Bisogno, Andrea Ferrari, Raquel Dávila Fajardo et al.
2026-10-27 Vol. 132 Issue 21
DOI: 10.1002/cncr.70661
Reply to “Structured rehabilitation for terminal cancer: Aligning the evidence with the setting that funds it”
Nanako Nishiyama, Yoshinobu Matsuda, Noriko Fujiwara et al.
2026-10-27 Vol. 132 Issue 21
DOI: 10.1002/cncr.70659
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 2, 2026 21:19